Nevro Corp. (NVRO)
NYSE: NVRO · Real-Time Price · USD
3.720
-0.330 (-8.15%)
Dec 27, 2024, 4:00 PM EST - Market closed
Nevro Market Cap
Nevro has a market cap or net worth of $139.39 million as of December 27, 2024. Its market cap has decreased by -81.35% in one year.
Market Cap
139.39M
Enterprise Value
109.29M
1-Year Change
-81.35%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since November 6, 2014, Nevro's market cap has decreased from $574.20M to $139.39M, a decrease of -75.72%. That is a compound annual growth rate of -13.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 27, 2024 | 139.40M | -82.11% |
| Dec 29, 2023 | 779.10M | -44.47% |
| Dec 30, 2022 | 1.40B | -50.42% |
| Dec 31, 2021 | 2.83B | -52.52% |
| Dec 31, 2020 | 5.96B | 63.52% |
| Dec 31, 2019 | 3.64B | 210.75% |
| Dec 31, 2018 | 1.17B | -42.66% |
| Dec 29, 2017 | 2.05B | -2.13% |
| Dec 30, 2016 | 2.09B | 10.82% |
| Dec 31, 2015 | 1.89B | 96.32% |
| Dec 31, 2014 | 960.70M | 67.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jin Medical International | 153.42M |
| Caribou Biosciences | 153.03M |
| Zura Bio | 151.48M |
| The Joint | 151.03M |
| Elutia | 149.31M |
| Puma Biotechnology | 148.24M |
| Adaptimmune Therapeutics | 148.11M |
| InflaRx | 147.80M |